A
AbCellera Biologics
Biotech & Life Sciences · Vancouver, Canada · Founded 2012 · IPO 2020 Unicorn
Global footprint
Where AbCellera Biologics has talent and traffic
(22 of 576 staff)
team presence
across markets
Patent intelligence
$63M patent portfolio · 45 active families
Where AbCellera Biologics concentrates vs peers
Each axis is a top-10 topic across AbCellera Biologics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
AbCellera Biologics's 5 investments and acquisitions.
Every disclosed deal where AbCellera Biologics appeared as a backer or acquirer, 2020–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
5 deals across AbCellera Biologics's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
AbCellera Biologics's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about AbCellera Biologics
An AI-synthesized read of the highest-engagement posts about AbCellera Biologics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AbCellera Biologics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.